Clinical trial
Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients…
NCT00500227 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00500227 |
|---|---|
| Title | Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery |
| Official title | Observational Study to Evaluate, in Acromegalic Patients With Disease Persistence After Surgery, Those Histopathologic, Clinical, Morphologic and Biochemical Factors Predictors of Hormonal Control Under Somatostatin Analogue Treatment |
| Acronym | ESPORA |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Acromegaly |
| Enrollment | 55 |
| Start date | Sep 1, 2007 |
| Primary completion | Jul 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Jul 12, 2007 |
| Last update posted | Jan 14, 2019 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: